4.8 Article

An enhanced CRISPR repressor for targeted mammalian gene regulation

Journal

NATURE METHODS
Volume 15, Issue 8, Pages 611-+

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/s41592-018-0048-5

Keywords

-

Funding

  1. NIH [RM1 HG008525, P50 HG005550]
  2. National Cancer Institute [5T32CA009216-34]
  3. Burroughs Wellcome Fund (Career Award for Medical Scientists)
  4. NIGMS [R35 GM119850]
  5. Novo Nordisk Foundation [NNF10CC1016517]
  6. DARPA (Young Faculty Award) [D16AP00047]
  7. Arizona State University Fulton Schools of Engineering startup fund
  8. Paul G. Allen Frontiers Group

Ask authors/readers for more resources

The RNA-guided endonuclease Cas9 can be converted into a programmable transcriptional repressor, but inefficiencies in target-gene silencing have limited its utility. Here we describe an improved Cas9 repressor based on the C-terminal fusion of a rationally designed bipartite repressor domain, KRAB-MeCP2, to nuclease-dead Cas9. We demonstrate the system's superiority in silencing coding and noncoding genes, simultaneously repressing a series of target genes, improving the results of single and dual guide RNA library screens, and enabling new architectures of synthetic genetic circuits.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available